Oorsprong van het eerstegraads netwerk van Stanley J. Cherelstein
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Internet Retail | 6 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Stanley J. Cherelstein via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| Imperial College London | College/University | Doctorate Degree | |
ReceptoPharm, Inc.
 ReceptoPharm, Inc. Pharmaceuticals: MajorHealth Technology ReceptoPharm, Inc. develops proprietary therapeutic protein products for the prevention and treatment of viral and neurological diseases. It provides benefits for patients with such diseases as acquired immunodeficiency syndrome, multiple sclerosis, myasthenia gravis, and other viral disorders. The company was founded on June 4, 2001 and is headquartered in Plantation, FL. | Pharmaceuticals: Major | Chief Executive Officer President | |
| Miami University | College/University | Undergraduate Degree | |
| United States Naval Academy | College/University | Undergraduate Degree | |
| Pepperdine University | College/University | Masters Business Admin | |
| St. John's University | College/University | Graduate Degree | |
| Trinity College Dublin | College/University | Undergraduate Degree | |
| St. Lawrence University | College/University | Undergraduate Degree | |
| Dhaka International University | College/University | Doctorate Degree | |
| State University of New York at Downstate Medical Center | College/University | Doctorate Degree | |
| Je Research, Inc. | Sales & Marketing | ||
| Biogenix, Inc. | Founder | ||
| Histologix LLC | Director/Board Member | ||
| Tryon Corp. | Founder | ||
Biotherapeutics, Inc.
 Biotherapeutics, Inc. BiotechnologyHealth Technology Biotherapeutics, Inc. operates as a pre-clinical stage company which develops small-molecule drugs to treat inflammation and type 2 diabetes. Its scientific foundation is anchored on informatics and computer modeling-enabled drug development with significant animal pharmacology validation. The company was founded by Josep Bassaganya-Riera in 2008 and is headquartered in Blacksburg, VA. | Biotechnology | Corporate Officer/Principal | |
| Project Scheduling Services, Inc. | Founder | ||
Khandaker Morgan Group, Inc.
 Khandaker Morgan Group, Inc. Financial ConglomeratesFinance Khandaker Morgan Group, Inc. provides investment services. The company was founded by Tanvir A. Khandaker on December 23, 2009 and is headquartered in New York, NY. | Financial Conglomerates | Founder |
Statistieken
Internationaal
| Verenigde Staten | 16 |
| Verenigd Koninkrijk | 2 |
| Ierland | 2 |
| Bangladesh | 2 |
Sectoraal
| Consumer Services | 10 |
| Health Technology | 3 |
| Finance | 3 |
Operationeel
| Director/Board Member | 9 |
| President | 6 |
| Founder | 5 |
| Undergraduate Degree | 4 |
| Doctorate Degree | 4 |
Sterkste connecties
- Beurs
- Insiders
- Stanley J. Cherelstein
- Bedrijfsconnecties
